Elucidating the clinical and genetic spectrum of inositol polyphosphate phosphatase INPP4A-related neurodevelopmental disorder
Lettie E Rawlins,Reza Maroofian,Stuart J Cannon,Muhannad Daana,Mina Zamani,Shamsul Ghani,Joseph S Leslie,Nishanka Ubeyratna,Nasar Khan,Hamid Khan,Annarita Scardamaglia,Robin Cloarec,Shujaat Ali Khan,Muhammad Umair,Saeid Sadeghian,Hamid Galehdari,Almundher Al-Maawali,Adila Al-Kindi,Reza Azizimalamiri,Gholamreza Shariati,Faraz Ahmad,Amna Al-Futaisi,Pedro M Rodriguez Cruz,Ainara Salazar-Villacorta,Moustapha Ndiaye,Amadou G Diop,Alireza Sedaghat,Alihossein Saberi,Mohammad Hamid,Maha S Zaki,Barbara Vona,Daniel Owrang,Abdullah M Alhashem,Makram Obeid,Amjad Khan,Ahmad Beydoun,Marwan Najjar,Homa Tajsharghi,Giovanni Zifarelli,Peter Bauer,Wejdan S Hakami,Amal M Al Hashem,Rose-Mary N Boustany,Lydie Burglen,Shahryar Alavi,Adam C Gunning,Martina Owens,Ehsan G Karimiani,Joseph G Gleeson,Mathieu Milh,Somaya Salah,Jahangir Khan,Volker Haucke,Caroline F Wright,Lucy McGavin,Orly Elpeleg,Muhammad I Shabbir,Henry Houlden,Michael Ebner,Emma L Baple,Andrew H Crosby
DOI: https://doi.org/10.1016/j.gim.2024.101278
2024-09-20
Abstract:Purpose: Biallelic INPP4A variants have recently been associated with severe neurodevelopmental disease in single case reports. Here, we expand and elucidate the clinical-genetic spectrum and provide a pathomechanistic explanation for genotype-phenotype correlations. Methods: Clinical and genomic investigations of 30 individuals were undertaken alongside molecular and in silico modelling and translation reinitiation studies. Results: We characterize a clinically variable disorder with cardinal features including global developmental delay, severe-profound intellectual disability, microcephaly, limb weakness, cerebellar signs and short stature. A more severe presentation associated with biallelic INPP4A variants downstream of exon 4 has additional features of (ponto)cerebellar hypoplasia, reduced cerebral volume, peripheral spasticity, contractures, intractable seizures and cortical visual impairment. Our studies identify the likely pathomechanism of this genotype-phenotype correlation entailing translational reinitiation in exon 4 resulting in an N-terminal truncated INPP4A protein retaining partial functionality, associated with less severe disease. We also identified identical reinitiation site conservation in Inpp4a-/- mouse models displaying similar genotype-phenotype correlation. Additionally, we show fibroblasts from a single affected individual exhibit disrupted endocytic trafficking pathways, indicating the potential biological basis of the condition. Conclusion: Our studies comprehensively characterise INPP4A-related neurodevelopmental disorder and suggest genotype-specific clinical assessment guidelines. We propose the potential mechanistic basis of observed genotype-phenotype correlations entails exon 4 translation reinitiation.